Manulife (Manufacturers Life Insurance)’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.47M | Buy |
191,097
+23,002
| +14% | +$157K | ﹤0.01% | 1630 |
|
|
2025
Q4 | $333K | Buy |
168,095
+18,776
| +13% | +$42.5K | ﹤0.01% | 2326 |
|
|
2025
Q3 | $367K | Buy |
149,319
+27,894
| +23% | +$71.8K | ﹤0.01% | 2320 |
|
|
2025
Q2 | $321K | Buy |
121,425
+18,278
| +18% | +$49.1K | ﹤0.01% | 2372 |
|
|
2025
Q1 | $310K | Buy |
103,147
+9,792
| +10% | +$29.7K | ﹤0.01% | 2328 |
|
|
2024
Q4 | $239K | Sell |
93,355
-1,555
| -2% | -$6.48K | ﹤0.01% | 2544 |
|
|
2024
Q3 | $353K | Buy |
94,910
+543
| +0.6% | +$2.51K | ﹤0.01% | 2405 |
|
|
2024
Q2 | $596K | Buy |
94,367
+12,738
| +16% | +$84K | ﹤0.01% | 2134 |
|
|
2024
Q1 | $438K | Buy |
81,629
+21,451
| +36% | +$97.1K | ﹤0.01% | 2257 |
|
|
2023
Q4 | $302K | Buy |
60,178
+14,532
| +32% | +$45.6K | ﹤0.01% | 2410 |
|
|
2023
Q3 | $77.1K | Sell |
45,646
-1,277
| -3% | -$2.56K | ﹤0.01% | 2878 |
|
|
2023
Q2 | $130K | Buy |
46,923
+6,946
| +17% | +$19.6K | ﹤0.01% | 2755 |
|
|
2023
Q1 | $72.8K | Buy |
39,977
+227
| +0.6% | +$706 | ﹤0.01% | 2808 |
|
|
2022
Q4 | $202K | Buy |
39,750
+194
| +0.5% | +$1.06K | ﹤0.01% | 2575 |
|
|
2022
Q3 | $197K | Sell |
39,556
-878
| -2% | -$4K | ﹤0.01% | 2598 |
|
|
2022
Q2 | $150K | Buy |
40,434
+4,796
| +13% | +$19.3K | ﹤0.01% | 2792 |
|
|
2022
Q1 | $200K | Sell |
35,638
-5,985
| -14% | -$36.7K | ﹤0.01% | 2777 |
|
|
2021
Q4 | $253 | Buy |
41,623
+1,155
| +3% | +$8.68K | ﹤0.01% | 2744 |
|
|
2021
Q3 | $394K | Sell |
40,468
-2,083
| -5% | -$22.9K | ﹤0.01% | 2462 |
|
|
2021
Q2 | $608K | Buy |
42,551
+23,375
| +122% | +$386K | ﹤0.01% | 2296 |
|
|
2021
Q1 | $455K | Sell |
19,176
-1,418
| -7% | -$36.8K | ﹤0.01% | 2342 |
|
|
2020
Q4 | $275K | Buy |
20,594
+1,783
| +9% | +$17.2K | ﹤0.01% | 2573 |
|
|
2020
Q3 | $130K | Hold |
18,811
| – | – | ﹤0.01% | 2726 |
|
|
2020
Q2 | $204K | Buy |
+18,811
| New | +$106K | ﹤0.01% | 2488 |
|
|
2018
Q3 | – | Sell |
-2,567
| Closed | -$8K | – | 3372 |
|
|
2018
Q2 | $8K | Hold |
2,567
| – | – | ﹤0.01% | 3947 |
|
|
2018
Q1 | $10K | Sell |
2,567
-23,588
| -90% | -$103K | ﹤0.01% | 3910 |
|
|
2017
Q4 | $117K | Buy |
26,155
+6,027
| +30% | +$28.5K | ﹤0.01% | 3346 |
|
|
2017
Q3 | $111K | Sell |
20,128
-7,444
| -27% | -$45.9K | ﹤0.01% | 3293 |
|
|
2017
Q2 | $210K | Buy |
27,572
+25,295
| +1,111% | +$109K | ﹤0.01% | 2969 |
|
|
2017
Q1 | $8K | Sell |
2,277
-3,410
| -60% | -$16.8K | ﹤0.01% | 3684 |
|
|
2016
Q4 | $33K | Sell |
5,687
-548
| -9% | -$3.66K | ﹤0.01% | 3513 |
|
|
2016
Q3 | $49K | Buy |
6,235
+3,958
| +174% | +$29.6K | ﹤0.01% | 3397 |
|
|
2016
Q2 | $14K | Sell |
2,277
-1,169
| -34% | -$9.07K | ﹤0.01% | 3581 |
|
|
2016
Q1 | $29K | Buy |
+3,446
| New | +$32.5K | ﹤0.01% | 3414 |
|
Other funds holding IBRX
VPM
VCM
HF
WP
Manulife (Manufacturers Life Insurance)'s IBRX Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) increased its ImmunityBio (IBRX) stake by 14% in Q1 2026, buying an estimated $157K and bringing the position to 191,097 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1630.
Manulife (Manufacturers Life Insurance) first reported a position in IBRX in Q1 2016 and has held it in 34 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 191,097 shares of ImmunityBio worth $1.47M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) bought 23,002 ImmunityBio shares in Q1 2026, an estimated $157K.
- ImmunityBio made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1630 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in ImmunityBio in Q1 2016 and has held it in 34 quarters since.
- 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.